Verification evidence is still being completed.
Bioceltix
Wroclaw, Poland
- Verified lead
- Łukasz Bzdzion
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- President of the Management Board
- 2026 technical specialization
- Veterinary Biologics, Cell Therapy, Animal Health, and Allogeneic Product Development
- Review cycle
- May 2026
- Full address
- ul. Bierutowska 57-59, bud. III, 51-317 Wroclaw, Poland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Bioceltix management-board disclosure.
- Editorial note
- Veterinary cell-therapy and biologics node extending Wroclaw into advanced animal-health product development.
Veterinary Biologics, Cell Therapy, Animal Health, and Allogeneic Product Development
Biological-drug development quality systems, Veterinary therapeutics governance
Veterinary cell-therapy and biologics node extending Wroclaw into advanced animal-health product development.
Bioceltix
Veterinary Biologics, Cell Therapy, Animal Health, and Allogeneic Product Development · Veterinary biologics platform
Verified 15 Mar 2026 · 3 sources
Veterinary cell-therapy and biologics node extending Wroclaw into advanced animal-health product development.
- Website
- bioceltix.com
- Company page
- Lead
- Łukasz Bzdzion (verified ↗)
- Compliance
- GLP
- Last reviewed
- 15 Mar 2026 (3mo ago)
- Scale
- Veterinary biologics platform
- Capabilities
- Veterinary biologics development · Cell-therapy platform research · Animal-health product design
- Founded
- 2018
- Headcount
- 11-50
Łukasz Bzdzion
President of the Management Board
Official Bioceltix contact page listing ul. Bierutowska 57-59, bud. III in Wroclaw.
Open sourceVeterinary biologics platform
Wroclaw, Poland. Veterinary Biologics, Cell Therapy, Animal Health, and Allogeneic Product Development. Review completed on 15 Mar 2026.
Polish and EU veterinary biologics and development framework
Biological-drug development quality systems, Veterinary therapeutics governance
Veterinary Biologics, Cell Therapy, Animal Health, and Allogeneic Product Development
Veterinary cell-therapy and biologics node extending Wroclaw into advanced animal-health product development.
Bioceltix broadens the Polish layer into veterinary biologics and cell-based therapeutics with an officially disclosed board president and current pipeline surface.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- VERIFIED ACTIVE 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Bioceltix located?
- Bioceltix operates from ul. Bierutowska 57-59, bud. III, 51-317 Wroclaw, Poland, Wroclaw, Poland.
- Who runs Bioceltix?
- Bioceltix is led by Łukasz Bzdzion, President of the Management Board. Verified 15 Mar 2026.
- What does Bioceltix do?
- Veterinary cell-therapy and biologics node extending Wroclaw into advanced animal-health product development. Core capabilities: Veterinary biologics development, Cell-therapy platform research, Animal-health product design, Preclinical and translational execution.
Related technical briefs
Briefs that name Wroclaw as a covered market or city.
